General Announcement::Board Meeting Intimation

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
01-Feb-2021 19:41:18
Status
New
Announcement Sub Title
Board Meeting Intimation
Announcement Reference
SG210201OTHR9HSV
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
01/02/2021 17:10:00
Description (Please provide a detailed description of the event in the box below)
We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Friday, February 12, 2021, inter alia, to consider and approve the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2020.

Attachments

SGX_BM_Intimation_01022021.pdf
Total size =45K